We are live on ! Find out more
GS

Gagnon Securities Portfolio holdings

AUM $519M
1-Year Est. Return 44.91%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$496M
AUM Growth
-$8.05M
Cap. Flow
-$33.6M
Cap. Flow %
-6.78%
Top 10 Hldgs %
48.27%
Holding
105
New
3
Increased
34
Reduced
50
Closed
14

Top Buys

Rank Stock Value
1
NCNO icon
nCino
NCNO
+$4.65M
2
AMRC icon
Ameresco
AMRC
+$3.03M
3
ETWO
E2open Parent Holdings
ETWO
+$1.87M
4
VRN
Veren
VRN
+$1.83M
5
PROF
Profound Medical
PROF
+$1.42M

Sector Composition

Rank Sector Weight
1 Healthcare 39.58%
2 Industrials 17.38%
3 Technology 17.33%
4 Consumer Discretionary 10.94%
5 Energy 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AL
1
DELISTED
Air Lease Corp
AL
$35.4M 7.14%
734,867
+1,223
+0.2% +$57.7K
ISRG icon
2
Intuitive Surgical
ISRG
$133B
$30.9M 6.22%
59,161
-2,909
-5% -$1.52M
CDNA icon
3
CareDx
CDNA
$2.35B
$30.6M 6.17%
1,431,196
-6,526
-0.5% -$159K
ENSG icon
4
The Ensign Group
ENSG
$10.4B
$29.3M 5.91%
220,725
-14,106
-6% -$2.05M
WGS icon
5
GeneDx Holdings
WGS
$2.08B
$27.6M 5.57%
359,376
-182,567
-34% -$12.8M
PSIX
6
Power Solutions International
PSIX
$759M
$25.3M 5.1%
850,146
-169,481
-17% -$4.94M
EPD icon
7
Enterprise Products Partners
EPD
$81.6B
$15.6M 3.15%
498,190
-3,072
-0.6% -$94.4K
CARG icon
8
CarGurus
CARG
$3.28B
$15.2M 3.06%
414,998
-264
-0.1% -$9.06K
FIVN icon
9
FIVE9
FIVN
$2.27B
$14.9M 3%
366,096
+34,597
+10% +$1.25M
BLFS icon
10
BioLife Solutions
BLFS
$1.65B
$14.7M 2.97%
567,215
-2,163
-0.4% -$53.8K
EXAS
11
DELISTED
Exact Sciences
EXAS
$13.8M 2.79%
246,204
+12,621
+5% +$785K
AMRC icon
12
Ameresco
AMRC
$1.36B
$13.4M 2.7%
571,202
+104,861
+22% +$3.03M
FRSH icon
13
Freshworks
FRSH
$3.18B
$13.2M 2.66%
815,771
-104,474
-11% -$1.48M
TMCI icon
14
Treace Medical Concepts
TMCI
$310M
$13.2M 2.65%
1,767,933
-2,230
-0.1% -$14.9K
NVGS icon
15
Navigator Holdings
NVGS
$1.27B
$13.1M 2.64%
852,608
+57,966
+7% +$912K
KMX icon
16
CarMax
KMX
$8.04B
$13M 2.62%
159,147
+321
+0.2% +$25.2K
PROF
17
Profound Medical
PROF
$290M
$12.4M 2.5%
1,652,531
+185,284
+13% +$1.42M
EQIX icon
18
Equinix
EQIX
$104B
$12.1M 2.44%
12,841
-30
-0.2% -$27.6K
BL icon
19
BlackLine
BL
$1.79B
$12M 2.42%
197,278
+12,292
+7% +$733K
CAKE icon
20
Cheesecake Factory
CAKE
$5.23B
$10.3M 2.09%
218,157
-644
-0.3% -$29.6K
VERX icon
21
Vertex
VERX
$1.91B
$9.38M 1.89%
175,810
-1,302
-0.7% -$63.1K
CMG icon
22
Chipotle Mexican Grill
CMG
$43.7B
$8.93M 1.8%
148,159
-583
-0.4% -$35.1K
GNRC icon
23
Generac Holdings
GNRC
$12.8B
$8.48M 1.71%
54,682
-74
-0.1% -$12.8K
AOSL icon
24
Alpha and Omega Semiconductor
AOSL
$974M
$7.93M 1.6%
214,105
-846
-0.4% -$31.5K
SAM icon
25
Boston Beer
SAM
$1.92B
$6.71M 1.35%
22,380
-75
-0.3% -$22.6K

Similar funds

Gagnon Securities's Q4 2024 Portfolio in Review

As of Q4 2024, Gagnon Securities held 105 positions worth $496M, down 1.6% from $504M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Gagnon Securities withdrew a net $33.6M in Q4 2024, closing 14 positions and reducing 50 holdings. Its most notable exit was Zuora, Inc., an estimated $9.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Industrials and Technology.

Against the trend, Gagnon Securities opened a new position in nCino worth $4.19M.

  • Gagnon Securities's largest Q4 2024 buy was nCino: 124,759 shares worth $4.19M.
  • Gagnon Securities added most to Ameresco in Q4 2024, an estimated $3.03M increase.
  • Gagnon Securities's biggest Q4 2024 reduction was GeneDx Holdings, cutting an estimated $12.8M.
  • Gagnon Securities fully exited Zuora, Inc. in Q4 2024, selling an estimated $9.05M.
  • Gagnon Securities's ten largest holdings make up 48% of its $496M portfolio in Q4 2024.
  • Gagnon Securities opened 3 new positions and closed 14 in Q4 2024.
  • Gagnon Securities's portfolio value fell 1.6% quarter-over-quarter to $496M.

Based on Gagnon Securities's 13F filing for Q4 2024, filed 24 Jan 2025.